Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Wellcome Trust | OTHER |
| University Hospital Southampton NHS Foundation Trust | OTHER |
| Imperial College Healthcare NHS Trust | OTHER |
| Heart of England NHS Foundation Trust |
Not provided
Not provided
Not provided
Not provided
A case-control study to investigate whether job exposures are an under-recognized cause of idiopathic pulmonary fibrosis (IPF) using an interview to collect information about previous jobs and a blood test to investigate genetic susceptibility.
Idiopathic pulmonary fibrosis (IPF) is a scarring lung disease. It damages the air sacs that allow oxygen to be transferred into the blood and transported to vital organs. These changes make people with IPF cough and feel short of breath. It not known what causes the damage. People who get IPF are usually older than 40; it's a very serious illness that cannot be cured and gets worse over time. Statistics show that IPF is becoming more common in the UK but it's not known why. It can be difficult for doctors to tell if someone has IPF or another disease called asbestosis.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Case | Males with an incident diagnosis of IPF made between the 1st of February 2017 and the 5th of October 2019. |
| |
| Controls | Males with an incident hospital outpatient attendance between the 1st of February 2017 and the 5th of October 2019 who do not have a diagnosis of IPF. At each participating centre a control clinic is randomly selected from all control clinics that the research team is able to recruit from; this clinic is the source clinic for controls for the duration of the study. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Computer-assisted telephone interview | Other | Occupational history |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Association between asbestos exposure and IPF | estimated using logistic regression for any vs no asbestos exposure and adjusting for age and smoking status | 2 years |
| Measure | Description | Time Frame |
|---|---|---|
| Dose-response relationship between asbestos exposure and IPF | estimated using logistic regression for categories of cumulative exposure and adjusting for age and smoking status | 2 years |
| Gene-environment interaction (for MUC5B rs35705950 and asbestos exposure) odds ratio. |
Not provided
For cases
Inclusion Criteria:
Exclusion Criteria:
For controls
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Hospital based
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Carl Reynolds | Imperial College London | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Imperial Healthcare NHS Trust | London | United Kingdom |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 36635100 | Derived | Reynolds CJ, Sisodia R, Barber C, Moffatt M, Minelli C, De Matteis S, Cherrie JW, Newman Taylor A, Cullinan P. What role for asbestos in idiopathic pulmonary fibrosis? Findings from the IPF job exposures case-control study. Occup Environ Med. 2023 Feb;80(2):97-103. doi: 10.1136/oemed-2022-108404. Epub 2023 Jan 12. |
| Label | URL |
|---|---|
| Full study documentation | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | Mar 22, 2021 | |
| Reset | Apr 15, 2021 | |
| Release | Nov 26, 2021 | |
| Reset | Jan 27, 2022 | |
| Release | Oct 20, 2023 | |
| Reset | Apr 12, 2024 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Mar 22, 2021 | Apr 15, 2021 | |||
| Nov 26, 2021 |
| ID | Term |
|---|---|
| D054990 | Idiopathic Pulmonary Fibrosis |
| ID | Term |
|---|---|
| D011658 | Pulmonary Fibrosis |
| D017563 | Lung Diseases, Interstitial |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D005820 | Genetic Testing |
| ID | Term |
|---|---|
| D019411 | Clinical Laboratory Techniques |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
| D008919 | Investigative Techniques |
Not provided
Not provided
| UNKNOWN |
| Liverpool University Hospitals NHS Foundation Trust | OTHER_GOV |
| Papworth Hospital NHS Foundation Trust | OTHER_GOV |
| Nottingham University Hospitals NHS Trust | OTHER |
| University Hospital of South Manchester | UNKNOWN |
| Guy's and St Thomas' NHS Foundation Trust | OTHER |
| North Bristol NHS Trust | OTHER |
| The Leeds Teaching Hospitals NHS Trust | OTHER |
| Newcastle-upon-Tyne Hospitals NHS Trust | OTHER |
| Royal Devon and Exeter NHS Foundation Trust | OTHER |
| Somerset NHS Foundation Trust | OTHER |
| Royal Infirmary of Edinburgh | OTHER |
| Morriston Hospital | UNKNOWN |
| Aberdeen Royal Infirmary | OTHER |
| Worcestershire Acute Hospitals NHS Trust | OTHER |
| University Hospital Birmingham NHS Foundation Trust | OTHER |
| Portsmouth Hospitals NHS Trust | OTHER_GOV |
| Norfolk and Norwich University Hospitals NHS Foundation Trust | OTHER |
| Glasgow Royal Infirmary | OTHER |
Not provided
Not provided
Not provided
blood
| Genetic analysis |
| Genetic |
To include analysis of known susceptibility markers |
|
MUC5B rs35705950 and asbestos exposure odds ratio. |
| 2 years |
| Jan 27, 2022 |
| Oct 20, 2023 | Apr 12, 2024 |
| D005821 | Genetic Techniques |
| D033142 | Genetic Services |
| D006296 | Health Services |
| D005159 | Health Care Facilities Workforce and Services |
| D003954 | Diagnostic Services |
| D011314 | Preventive Health Services |